Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokine induction by a bacterial DNA-specific modified base.

Hiroyuki Tsuchiya1, Tadashi Matsuda, Hideyoshi Harashima

  • 1Laboratory for Molecular Design of Pharmaceutics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

Biochemical and Biophysical Research Communications
|December 21, 2004
PubMed
Summary

Bacterial N(6)-methyladenine (N(6)-MeA) DNA, like unmethylated CpG DNA, triggers inflammatory cytokine production in mammals. This discovery suggests potential applications for N(6)-MeA DNA in immunotherapy and vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel bivalent neoantigen vaccine based on mRNA-loaded lipid nanoparticles eradicates hepatocellular carcinoma in mice.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Lipid nanoparticles containing zwitterionic lipids versatilely enhance the efficiency of mRNA delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Mitochondria-targeted coenzyme Q<sub>10</sub> nanocarriers evaluated by particle size and lipid composition alleviate early acetaminophen-induced liver injury.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Examining the Impact of Storage Conditions on the Stability of a Liquid Formulation of mRNA-Loaded Lipid Nanoparticles.

Pharmaceutics·2025
Same author

Lipid nanoparticle delivery of the CRISPR/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8).

Scientific reports·2025
Same author

Microfluidic Production of Exosome-Mimicking Lipid Nanoparticles for Enhanced RNA Delivery: Role of Exosomal Proteins.

ACS applied materials & interfaces·2025

Area of Science:

  • Immunology
  • Molecular Biology
  • Microbiology

Background:

  • Unmethylated CpG dinucleotides in DNA are known activators of the mammalian inflammatory response.
  • Bacterial DNA contains unique modified bases, such as N(6)-methyladenine (N(6)-MeA), which may also influence host immunity.

Purpose of the Study:

  • To investigate whether N(6)-MeA, a bacterium-specific DNA modification, can also stimulate the mammalian immune system.
  • To explore the potential of N(6)-MeA-containing DNA in immunomodulation and therapeutic applications.

Main Methods:

  • Administration of oligodeoxynucleotides (ODNs) containing N(6)-MeA to mice.
  • Co-injection of N(6)-MeA ODNs with CpG ODNs.
  • Complexation of N(6)-MeA-containing plasmid DNA with cationic lipids and subsequent injection.

Related Experiment Videos

Main Results:

  • ODNs containing N(6)-MeA induced cytokine production when injected into mice.
  • Co-administration of N(6)-MeA and CpG ODNs resulted in a 2- to 3-fold enhancement of cytokine levels compared to CpG ODNs alone.
  • N(6)-MeA-containing plasmid DNA, when delivered via cationic lipids, induced Interleukin-12 (IL-12) production.

Conclusions:

  • The bacterium-specific base N(6)-MeA, in addition to unmethylated CpG motifs, can trigger mammalian immune responses.
  • N(6)-MeA-containing DNA holds promise as a tool for enhancing cellular immunotherapy and developing DNA vaccines.